This is filed to report hemolysis.It was reported that on (b)(6) 2022, a mitraclip procedure was performed to treat functional mitral regurgitation (mr) with grade of 4+.One clip was implanted with no reported issue, reducing mr to grade 1+.On (b)(6) 2023, the physician stated that the patient has hemolysis that was caused by the implanted mitraclip.The patient is being considered for surgery to have the clip removed and valve replacement.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the reported hemolysis appears to be due to the clip implant interacting with patient pathology.The reported patient effect of hemolysis, as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.The reported minor injury/ illness/ impairment was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|